Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Everolimus impurity 10 is a known impurity of the immunosuppressant Everolimus, which targets the mTOR signaling pathway. This impurity is critical for assessing the purity and quality of Everolimus formulations in pharmacological research. It serves as a reference standard in stability studies, quality control, and regulatory compliance for pharmaceutical development. -
Drug Impurity
Rosuvastatin impurity 13 calcium is a chemical impurity associated with Rosuvastatin calcium, which acts as an HMG-CoA reductase inhibitor. This compound is essential for quality control in pharmaceutical formulations, providing insight into the purity and stability of Rosuvastatin products. Researchers utilize this impurity to assess drug formulations and ensure compliance with regulatory standards in therapeutic applications. -
Drug Impurity
Palbociclib impurity 9 is a known impurity of Palbociclib, a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6). This compound is utilized primarily in the quality control and analytical characterization of Palbociclib, aiding in the assessment of compound purity and efficacy. Its evaluation is essential for ensuring compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Mirabegron impurity 4 is a chemical impurity associated with the drug Mirabegron, a beta-3 adrenergic receptor agonist. This impurity is important for assessing the purity and quality of Mirabegron formulations in pharmaceutical research. Its characterization is crucial for ensuring compliance with regulatory standards and for conducting stability studies in drug development. -
Pantoprazole Impurity
Pantoprazole N-oxide is a known impurity associated with the synthesis of Pantoprazole, a proton pump inhibitor (PPI) utilized in the treatment of conditions linked to excessive gastric acid, including gastric ulcers and gastroesophageal reflux disease (GERD). This compound is valuable for analytical research and quality control processes, aiding in the characterization and assessment of Pantoprazole formulations. Its presence in pharmaceutical development highlights the importance of monitoring impurities to ensure product safety and efficacy. -
Drug Impurity
Budesonide impurity 90 is a known impurity associated with the corticosteroid Budesonide. This compound serves as an important analytical standard for the characterization and quality control of Budesonide formulations. Researchers can utilize Budesonide impurity 90 in studies focused on the detection and quantification of impurities to ensure compliance with pharmaceutical regulations and to enhance the safety and efficacy profiles of corticosteroid therapies. -
Drug Impurity
Metoprolol impurity 5 is a chemical impurity associated with Metoprolol, a beta-adrenergic blocker. This compound serves as a valuable reference material for quality control and analytical validation in pharmaceutical research, particularly in the development and testing of Metoprolol formulations. Its analysis is crucial for ensuring the purity and safety of Metoprolol-containing products. -
Drug Impurity
Cinacalcet impurity 2 is a chemical impurity associated with the therapeutic agent Cinacalcet. This compound serves as an important reference standard for the analysis and characterization of Cinacalcet formulations. Its presence may be monitored during drug development processes to ensure quality control and compliance with regulatory standards. Researchers can utilize this impurity in various applications, including stability studies and purity assessment in pharmaceutical research. -
Drug Impurity
Tenofovir impurity 7, also known as Tenofovir disoproxil dimer, is a chemical impurity associated with the antiviral drug Tenofovir. This compound is critical for assessing the purity and safety of Tenofovir formulations in pharmaceutical development. It serves as a key reference standard in analytical studies and quality control processes aimed at ensuring compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Rivastigmine impurity 13, also known as Rivastigmine impurity D, is a characterized impurity associated with Rivastigmine, a cholinesterase inhibitor primarily used in the treatment of Alzheimer's disease and other dementias. This impurity may be utilized in quality control and analytical studies to assess the purity and composition of Rivastigmine formulations. Its presence highlights the importance of monitoring drug impurities to ensure safety and efficacy in pharmaceutical products. -
Drug Impurity
Buspirone impurity 1 oxalate is a known impurity associated with the synthesis of Buspirone oxalate. This compound is primarily utilized in the quality control and characterization of Buspirone formulations in pharmaceutical research. Its presence can influence the pharmacological properties of the drug, making it critical for studies focused on drug purity, stability, and efficacy assessments. -
Drug Impurity
Lopinavir impurity 1, also known as Lopinavir impurity K, is a chemical byproduct associated with Lopinavir synthesis. This impurity is important for quality control and characterization in pharmaceutical formulations. It aids researchers in evaluating the purity of Lopinavir products and understanding potential side effects or metabolic pathways in drug development. -
Drug Impurity
Tenofovir impurity 18 is a chemical impurity associated with Tenofovir. It serves as a critical reference standard in the analysis of Tenofovir formulations and aids in assessing the purity and quality of pharmaceutical products. This compound is essential for ensuring compliance with regulatory standards in drug development and quality control processes. -
Drug Impurity
Hydroxychloroquine impurity 5, also known as Hydroxychloroquine O-Sulfate, is a chemical impurity associated with the anti-parasitic compound Hydroxychloroquine. This impurity is of interest in pharmacological research for its potential effects on drug metabolism and safety profiling. Its characterization is essential for ensuring the quality and efficacy of Hydroxychloroquine formulations. -
Drug Impurity
Albendazole impurity 5 is a chemical impurity associated with the antiparasitic agent Albendazole. This compound is utilized in the quality control and characterization of Albendazole formulations. Its presence may impact the safety and efficacy of drug products, making it essential for pharmaceutical research and development. -
Terbutaline Impurity
(4RS)-2-(1,1-Dimethylethyl)-1,2,3,4-tetrahydroisoquinoline-4,6,8-triol hemisulfate is a known impurity of Terbutaline. This compound may serve as a reference standard in analytical chemistry for ensuring the purity of Terbutaline formulations. Its presence can be crucial for the quality control of pharmaceutical products, aiding in the development and validation of analytical methods. -
Drug Impurity
Bupropion impurity 1, also known as (S)-Bupropion, is a structural impurity associated with the pharmaceutical compound Bupropion. It is relevant in pharmaceutical research for studying the potential effects and safety profiles of drug formulations. This impurity can also assist in understanding metabolic pathways and elucidating the therapeutic activity of Bupropion in clinical applications. -
Drug Impurity
Hydrocortisone acetate impurity 2 is a chemically defined impurity derived from hydrocortisone acetate. This compound serves as an important reference standard in the assessment of drug quality and formulation. Its examination is critical for understanding the impurity profile during hydrocortisone acetate synthesis and ensuring the safety and efficacy of pharmaceutical products. This impurity is also valuable for analytical development and regulatory compliance in the pharmaceutical industry. -
Drug Impurity
Afatinib impurity 92 is a byproduct of Afatinib, a potent irreversible inhibitor of the epidermal growth factor receptor (EGFR) tyrosine kinase. This impurity is essential for quality control and characterization in pharmaceutical research and development, ensuring the purity and efficacy of EGFR-targeted therapies. It serves as a crucial component for analytical studies, providing insights into potential degradation pathways and stability assessment of Afatinib formulations. -
Drug Impurity
Linagliptin impurity 87 is a known impurity associated with Linagliptin, a selective DPP-4 inhibitor. This impurity is critical for the assessment of drug purity and quality in pharmaceutical development. Its analysis is important for ensuring compliance with regulatory standards in drug formulation and safety evaluations. -
Drug Impurity
Amoxicillin Impurity 6 is an impurity associated with Amoxicillin, a widely used beta-lactam antibiotic. This compound is valuable for quality control and analytical research in pharmaceutical development, aiding in the identification and characterization of drug impurities. Its study supports the assessment of drug purity and helps ensure compliance with regulatory standards in the manufacturing processes of antibiotics. -
Drug Impurity
Fusidic acid impurity 7 is a chemical impurity associated with fusidic acid. This compound serves as a critical reference standard for assessing the purity and quality of fusidic acid formulations. Its identification and quantification are essential in pharmaceutical research to ensure compliance with regulatory standards and to evaluate the safety and efficacy of drug products containing fusidic acid. -
Drug Impurity
Raloxifene impurity 6 is a known impurity of the selective estrogen receptor modulator, Raloxifene. This compound is utilized primarily in the evaluation of drug purity and the assessment of Raloxifene formulations in pharmaceutical development. Understanding its characteristics is essential for ensuring the quality and safety of therapeutic agents containing Raloxifene. -
Drug Impurity
Tamsulosin impurity 2 is an impurity associated with the drug Tamsulosin, primarily utilized in the treatment of benign prostatic hyperplasia. Its presence in formulations is critical for quality control and regulatory compliance. This reagent is valuable for analytical research and method development in pharmaceutical studies focusing on the safety and efficacy of Tamsulosin products. -
Drug Impurity
Aripiprazole impurity 7 is a known impurity associated with Aripiprazole. This compound serves as a useful reference standard in the development, quality control, and stability testing of pharmaceutical formulations containing Aripiprazole. Its identification and analysis can aid in ensuring the safety and efficacy of the drug in clinical applications. Researchers may utilize this impurity for analytical purposes in compliance with regulatory standards. -
Drug Impurity
Acyclovir impurity 7 is a known impurity of the antiviral agent Acyclovir. It is utilized primarily in drug quality control and analytical studies to ensure the purity and efficacy of pharmaceutical formulations. Research applications include assessing the stability, degradation pathways, and overall integrity of Acyclovir-related compounds in drug development processes. -
Drug Impurity
Rosuvastatin impurity 34 is a known impurity associated with the statin drug Rosuvastatin. This compound is primarily used for analytical and quality control applications in pharmaceutical research, particularly for the assessment of drug purity and stability. Its identification and quantification are essential for ensuring the safety and efficacy of Rosuvastatin formulations in clinical settings. -
Drug Impurity
Rosuvastatin impurity 43 is a known impurity of Rosuvastatin, a statin used for lowering cholesterol levels. This compound is critical in drug development and quality control for assessing the purity of Rosuvastatin formulations. Its identification and quantification are essential in ensuring the safety and efficacy of statin-based therapies. Research applications include method development for impurity analysis and stability testing. -
Camphor impurity
Isopropyl (1S)-(+)-10-camphorsulfate is identified as an impurity of camphor, a compound recognized for its topical anti-infective and anti-pruritic properties, as well as its efficacy as a stimulant and carminative when administered internally. This impurity serves as a critical reference point for researchers studying the safety and efficacy of camphor and its derivatives in various biological applications, including pharmacological investigations and formulation developments. -
Drug Impurity
Albendazole impurity 9 is a chemical compound identified as 6-(propylsulfonyl)-1H-benzimidazol-2-amine, serving as a drug impurity in pharmaceutical formulations. It plays a significant role in the quality control and analytical assessment of albendazole, facilitating the detection of potential side effects or contamination in drug products. This impurity is essential for researchers focusing on drug purity standards and metabolic studies. -
Albendazole Impurity
ABZ-amine, also known as Amino albendazole, is an impurity of albendazole, a benzimidazole compound with antiparasitic activity. This compound is primarily utilized in research to study the metabolic pathways and potential side effects of albendazole in various biological systems. Its relevance extends to investigations of drug efficacy and safety profiles in the context of anthelmintic treatments. -
Drug Impurity
Chlorthalidone impurity 7 is a known impurity associated with Chlorthalidone, a diuretic agent that inhibits the reabsorption of sodium and chloride in the distal convoluted tubule. This compound is relevant for quality control and method development in pharmaceutical research, particularly in the evaluation of drug purity and stability. Its identification and quantification are critical for ensuring the safety and efficacy of Chlorthalidone formulations. -
Impurity
Isopropyl benzenesulfonate is an aromatic sulfonate compound identified as a potential genotoxic impurity. This compound may be utilized in the study of chemical synthesis and impurity profiling within pharmaceutical development. Its role as an impurity allows researchers to assess safety and regulatory compliance for various chemical products. -
Drug Impurity
Carbamazepine impurity 7 is a chemical impurity associated with the anticonvulsant drug carbamazepine. It serves as a critical reference standard for analytical applications in pharmaceutical research and quality control, facilitating the identification and quantification of impurities in drug formulations. This reagent is essential for ensuring the safety and efficacy of carbamazepine and its derivatives in clinical settings. -
Drug Impurity
Nintedanib impurity 41 is a known impurity of the tyrosine kinase inhibitor Nintedanib, which primarily targets VEGFR, FGFR, and PDGFR pathways. This compound is essential for the characterization and quality control of Nintedanib formulations in pharmaceutical development. Its analysis can provide valuable insights into the stability and safety profiles of drug products for cancer and fibrotic diseases. -
Drug Impurity
Rivaroxaban impurity 48 is a key impurity associated with the anticoagulant Rivaroxaban, which acts as a selective factor Xa inhibitor. This impurity is essential for the characterization and quality control of Rivaroxaban in pharmaceutical formulations. Its analysis is crucial for ensuring the purity and safety of Rivaroxaban in drug development and research applications. -
Drug Impurity
Furosemide impurity 6 is a known impurity of the loop diuretic furosemide, which primarily targets the sodium-potassium-chloride cotransporter. This impurity may arise during the synthesis or degradation of furosemide and is important for quality control in pharmaceutical formulations. Its characterization is essential for ensuring the purity and safety of furosemide-containing medications used in clinical research and drug development. -
Nitrosamine Drug Substance-Related Impurity
N-Nitrosovancomycin is a nitrosamine drug substance-related impurity (NDSRI) associated with vancomycin hydrochloride. This compound is of particular interest in pharmaceutical research due to its relevance in drug safety assessments and regulatory compliance. Its presence can provide insights into the stability and degradation pathways of vancomycin in various formulations. -
Drug Impurity
Atenolol impurity 8 is a structural impurity associated with Atenolol, a selective beta-1 adrenergic receptor blocker. This compound is crucial for analyzing the purity of Atenolol formulations and evaluating potential impacts on drug efficacy and safety. It serves as an important reference standard in the pharmaceutical industry for quality control and compliance in drug development and analysis. -
Drug Impurity
Ranolazine impurity 3 is a chemical impurity associated with Ranolazine, primarily used as a reference standard in analytical and quality control applications. This compound is essential for ensuring the purity and consistency of Ranolazine formulations. Its characterization contributes to the understanding of metabolic pathways and the identification of potential degradation products. Research involving this impurity aids in enhancing the quality of pharmaceutical formulations and supports regulatory compliance in drug development processes. -
Drug Impurity
Olmesartan impurity 1 serves as a structural impurity related to the antihypertensive agent Olmesartan. This compound is essential for the analytical characterization of Olmesartan, particularly in the context of quality control and regulatory compliance in pharmaceutical development. Its presence and quantification can provide insights into the synthesis purity and stability profiles of Olmesartan formulations. -
Drug Impurity
Rivaroxaban impurity 67 is a defined impurity of the anticoagulant Rivaroxaban. This compound serves as a critical reference standard for analytical and quality control processes in the pharmaceutical industry. It aids in routine testing, stability analysis, and ensuring the purity of Rivaroxaban formulations in drug development and regulatory compliance. -
Drug Impurity
Cabozantinib impurity 7 is a synthetic impurity derivative of the tyrosine kinase inhibitor Cabozantinib. It serves as a crucial reference standard for quality control and analytical studies related to Cabozantinib production. This compound aids in the characterization and assessment of drug purity, essential for pharmacokinetics and toxicological research applications. -
Drug Impurity
Estradiol impurity 1 is a known impurity associated with the synthesis of Estradiol. This compound can serve as a critical reference for assessing the purity of Estradiol formulations in research and quality control applications. It is important for researchers studying the metabolism and pharmacokinetics of estrogenic compounds, as well as in the evaluation of drug safety and efficacy. -
Drug Impurity
Lifitegrast impurity 4 hydrochloride is a chemical impurity associated with Lifitegrast, primarily known for its role as a lymphocyte function-associated antigen-1 (LFA-1) antagonist. This impurity serves as a reference standard for analytical characterization and quality control in pharmacological studies of Lifitegrast. Research applications include assessing the purity of the active pharmaceutical ingredient and evaluating potential effects on drug efficacy and safety profiles. -
Drug Impurity
Sitagliptin impurity 25 is a known impurity associated with the DPP-4 inhibitor Sitagliptin, primarily targeting the Dipeptidyl Peptidase-4 enzyme. This compound is essential for quality control in the synthesis and analysis of Sitagliptin and is relevant for pharmacokinetic and toxicological studies. Its characterization supports research into drug formulation and regulatory compliance. -
Drug Impurity
Tamsulosin Impurity 6 serves as a drug impurity associated with the pharmaceutical compound tamsulosin. Its presence is critical for quality control and regulatory compliance during the manufacturing process. This compound is utilized in research applications to investigate the safety and efficacy of tamsulosin formulations, contributing to the understanding of potential impacts on drug performance and stability. -
Drug Impurity
Donepezil impurity 10 is a known impurity associated with the compound Donepezil, a reversible inhibitor of the enzyme acetylcholinesterase. This reagent is significant for analytical studies aimed at monitoring the purity of Donepezil in pharmaceutical formulations. It serves as a reference standard in quality control processes and method development, ensuring compliance with regulatory guidelines in drug manufacturing and research applications. -
Drug Impurity
Apixaban 4,5-dehydro carboxylic acid is a known drug impurity of Apixaban, an anticoagulant that functions primarily by inhibiting Factor Xa in the coagulation cascade. This compound serves as an important reference standard for analytical and stability studies in pharmaceutical development. Research applications include the assessment of drug purity, identification of degradation products, and evaluation of manufacturing processes. -
Drug Impurity
Tamsulosin impurity 21 is a chemical impurity associated with the drug Tamsulosin, which primarily targets the α1-adrenergic receptors. This impurity may serve as a valuable reference standard in the analysis of Tamsulosin formulations. Its identification is crucial for assessing the purity and quality of pharmaceutical products in drug development and quality control.
